-
April 26, 2013
Looking past the BRICs and broad index funds, Africa represents a huge ignored growth story.
-
April 10, 2013
Offering both growth and income potential, emerging market debt could be one of the best plays for your portfolio.
-
February 15, 2013
We recently reiterated our Neutral recommendation on Zimmer Holdings (ZMH), a leading orthopedic medical devices ...
-
February 15, 2013
As of now, currency ETF investing remains somewhat underappreciated by most. The space has just over three dozen ...
-
February 15, 2013
Switzerland-based Actelion Ltd. (ALIOF) reported fourth quarter 2012 earnings of 47 cents per American Depository ...
-
February 15, 2013
Incyte Corporation's (INCY) second-quarter 2012 earnings of 3 cents per share compared favorably with the year-ago ...
-
February 15, 2013
Health Management Associates (HMA), a leading operator of general acute care hospitals, reported fourth quarter and ...
-
February 14, 2013
Peregrine Pharmaceuticals (PPHM) recently announced phase II data on its oncology candidate, bavituximab. The ...
-
February 14, 2013
RTI International Metals, Inc. (RTI), the producer and supplier of titanium mill products, reported earnings of 23 ...
-
February 13, 2013
We recently reiterated our Neutral recommendation on Thermo Fisher Scientific (TMO), a major scientific instrument ...
-
February 13, 2013
Amgen (AMGN) recently provided an update on its long-term strategy. The company said that it intends to focus on the ...
-
February 13, 2013
Boston Scientific (BSX) has expanded its drug eluting stent ("DES") portfolio with the CE Mark approval for the ...
-
February 13, 2013
Seattle Genetics, Inc. (SGEN) reported fourth quarter 2012 net loss per share of 9 cents, narrower than the Zacks ...
-
February 12, 2013
On Feb 5, 2013, we reaffirmed our Neutral recommendation on Cepheid Inc (CPHD) following the fourth quarter 2012 ...
-
February 12, 2013
After reporting dismal results over the past six quarters, Avon Products Inc. (AVP) posted better-than-expected ...
-
February 12, 2013
Smith & Nephew plc (SNN) reported earnings per share (EPS) of 15.8 cents or EPADS of 79 cents in the fourth quarter ...
-
February 11, 2013
Eli Lilly and Company (LLY) recently provided an update on its rheumatoid arthritis candidate, tabalumab. The ...
-
February 08, 2013
Zacks Investment Research downgraded Graham Corp. (GHM) to a Zacks Rank #5 (Strong Sell) on February 6, 2013. Why ...
-
February 08, 2013
Accuray Incorporated's (ARAY) second-quarter fiscal 2013 adjusted loss of 30 cents per share was narrower than the ...
-
February 08, 2013
Hologic (HOLX) reported net income of $3.1 million or a penny per share in the first quarter of fiscal 2013 compared ...
